Bioceres, an Argentinian developer of crop productivity traits for genetically modified seeds, filed on Thursday with the SEC to raise up to $81 million in an initial public offering.
Bioceres has partnered with Arcadia Biosciences (RKDA), Dow (NYSE: DOW)...read more
Six companies went public in the past week, raising $1.4 billion. Half traded up 10% or more, and half had negative or no return. For the second week in a row, the general partner of a midstream natural gas pipelines MLP priced an upsized IPO above its...read more
Arcadia Biosciences, which is developing a portfolio of crop productivity traits for genetically modified seeds, raised $66 million by offering 8.2 million shares at $8. Before cutting its terms on Thursday, the company had planned to offer 7.2 million shares at...read more
Arcadia Biosciences, which is developing a portfolio of crop productivity traits for genetically modified seeds, lowered the proposed deal size for its upcoming IPO on Thursday. The Davis, CA-based company now plans to raise $66 million by offering 8.2...read more
A new GMO IPO: Bioceres files for an $81 million US IPO
Bioceres, an Argentinian developer of crop productivity traits for genetically modified seeds, filed on Thursday with the SEC to raise up to $81 million in an initial public offering. Bioceres has partnered with Arcadia Biosciences (RKDA), Dow (NYSE: DOW)...read more
US IPO Weekly Recap: With 6 IPOs, the year's largest company goes public
Six companies went public in the past week, raising $1.4 billion. Half traded up 10% or more, and half had negative or no return. For the second week in a row, the general partner of a midstream natural gas pipelines MLP priced an upsized IPO above its...read more
Arcadia Biosciences prices IPO at $8 after cutting proposed valuation
Arcadia Biosciences, which is developing a portfolio of crop productivity traits for genetically modified seeds, raised $66 million by offering 8.2 million shares at $8. Before cutting its terms on Thursday, the company had planned to offer 7.2 million shares at...read more
Cut the crop: Arcadia Biosciences slashes proposed IPO size by 34%
Arcadia Biosciences, which is developing a portfolio of crop productivity traits for genetically modified seeds, lowered the proposed deal size for its upcoming IPO on Thursday. The Davis, CA-based company now plans to raise $66 million by offering 8.2...read more